These data are consistent with a previous meta-analysis that linked downregulation of FCGRT, which codes for the alpha chains of FcRn, to lower overall survival in patients with hepatocellular carcinoma [111]. The gene discussed is FCGRT; the disease is hepatocellular carcinoma.